About AnGes
About AnGes
Top Message
Values
Mission
Business Area
Business Model
Company Profile
Board of Directors
Locations
History
Alliance Status
Pipeline
Pipeline
Main pipeline products
Product for HGF gene therapy
NF-κB Decoy Oligo DNA
Vaccine
Global Alliance
Global Alliance
EmendoBio, Inc.
MyBiotics Pharma Ltd.
Investor Relations
Investor Relations
IR News
Stock Performance
Financial Reports
Intellectual Property Reports
Other Information Materials
Analyst Report
IR STREET(IR related information)
IR STREET(Email Alerts)
Corporate Brochure
Contact us
COVID-19
Contact us
Site Policy
Privacy Policy
JP
EN
Leading Global in Gene Medicine
About AnGes
TOPIC
Our COVID-19 Related Project
News
All
Development
Product Info
IR
Information
2022.06.16
IR
Notice Regarding Posting of Non-operating Income
2022.05.11
IR
Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan
2022.05.10
IR
Consolidated Financial Report for the First Quarter 2022
2022.03.11
IR
Notice of the 23rd Annual General Meeting of Shareholders
2022.02.16
Information
Announcement U.S. Subsidiary (AnGes USA, Inc.) Office Relocation and the Appointment of Mr. Masami Yuhara as the CEO of AnGes USA, Inc.
Learn more
Pipeline
Learn more
Global Alliance
Learn more
Contact us